EBITDA has crashed among most of Europe's biggest hospital groups despite high single-digit revenue growth. Last-minute cancellations, supply chain issues and rising energy prices are all among the culprits.
UAE and Indian hospital business Aster DM has tasked bankers to look at a demerger between the two geographies. Chairman Azad Moopen has said this makes more room for capex on the high-growth Indian business.
The South African government made almost no use of private sector capacity during the pandemic, HBI hears, sending less than 100 COVID patients to be treated in the private sector. However, results point to a bounceback for the ‘Big Three’.
Quironsalud, the Spanish arm of Fresenus Helios has expanded its Colombian business with the acquisition of Centro Oncológico de Antioquia and ophthalmology centre Clínica Clofán. In its nine month results Fresenius stated that Latin America were strong and "notably above expectations." We look at a booming market where Fresenius Helios spent the lion's share of its €770m on M&A deals in 2020 and 2019 alone.
Russia has just started a new three-year pilot that allows specific providers to make remote diagnoses and prescriptions, it is one of the last countries in Europe to deregulate telehealth.
Pan-European booking platform Docplanner has made its first meaningful internationalisation in four years with the acquisition of German doctor-rating player Jameda. CFO Peter Bialo tells HBI that the recently-minted unicorn will be heading for another fundraising round in a year.
Australia's largest oncology provider Icon Group has been bought by EQT's infrastructure arm for AUS$2.4bn. Its CEO Mark Middleton tells HBI that the group now has its sights set on Europe.
Municipality-owned French care homes are in crisis. Tired, old buildings, with low tariffs and now, following Covid, far lower occupancy rates are leading many to consider the unthinkable: privatisation.
